C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.
about
Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureusStructure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein SbiInfectious diseases associated with complement deficiencies.Complement-mediated acute effects of liposome-encapsulated hemoglobin.Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococciNaturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes.Meningococcal disease and the complement system.Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model.Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis.Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding ProteinAnalysis of C3 deposition and degradation on Neisseria meningitidis and Neisseria gonorrhoeae.IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111.The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococciMolecular basis for serum resistance in Neisseria gonorrhoeae.Influence of serotype of group B streptococci on C3 degradation.Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway.Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa.Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2.In vivo enzymatic modulation of IgG antibodies prevents immune complex-dependent skin injury.Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.Complement and immunity to viruses.Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification.All Things Complement.C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.Immune complex-like moieties in immunoglobulin for intravenous use (i.v.Ig) bind complement and enhance phagocytosis of human erythrocytes.The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?
P2860
Q24646878-BC1928DC-0062-4572-9EDC-6BA1B6DE71EFQ24649766-E78DCBE7-E668-4F2A-9156-05C50EAEDBDEQ30450183-D666E124-152D-4633-AD7C-651DAA8AC768Q33537849-E0AD1FD7-6900-40A9-AFCA-21795A300CF7Q33596128-987D0B80-10C6-44F1-AEBD-AEF896B2D8FEQ33602473-743769A2-0E73-4B06-87BF-125FD2D35C16Q34356354-519B237B-A270-4B0B-910C-36B8D3F0F902Q34376170-31BA3ADA-C7C5-4CCB-B8FB-D77BB699EBDFQ34581633-44AD5F63-A483-4ECA-8C6A-3CD72EC88FDFQ34581644-2F45D887-5C60-4D72-932C-BA21CCC83514Q35766497-0549B4A0-3A2E-48D7-ADC5-EE8292B5C526Q35777766-F72E01AB-0D9C-4EAD-80D1-471B625D34BCQ35779576-6E1FD0F8-CEFE-4E32-9E9A-4D3A0DCE064EQ36350791-1FD47860-AB81-4BD9-906D-D9620562DFD7Q36354665-59BAD772-3D62-4429-B9F1-679448527324Q36634375-521F81DB-A39A-476C-B74B-4CBF1C5EB603Q36969922-206E9CF0-52C5-4E50-A556-6A8235FD5F50Q36993336-971DC54A-C0F4-4C4C-8A16-AE9D1EE4B30DQ37013891-E45C761F-00E3-4D68-8569-3C47497D65D2Q37051223-97B53FA2-9298-4DF6-854E-3480033C5B37Q38313673-5B50CF91-8FDE-40E3-8121-B6C40AB69FCDQ38832411-3EC2FC97-68BD-4D64-9866-8650809F4B4DQ38864097-6AB30C05-F717-4591-BC65-BFA3CE8442CCQ40162311-5FC740DD-DFDC-4F2F-8C57-69E1DF87D191Q41672927-5E047A43-D959-4097-B063-D65495DDDC92Q41822812-C65328F3-393C-450E-87A1-2E6A1D802241Q42386506-5F2A5DFF-DFD2-480E-ABD2-43762212FD23Q42821295-9FFB03AC-039B-404A-832E-FDE51C1AD4B8Q47712347-67068ABE-EFC3-4C63-898D-3B87B7081C4BQ49721910-5EEE03E0-8EDD-4F22-9C24-5B5753FBFAD1
P2860
C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
C3b covalently bound to IgG de ...... activation by factors H and I.
@ast
C3b covalently bound to IgG de ...... activation by factors H and I.
@en
type
label
C3b covalently bound to IgG de ...... activation by factors H and I.
@ast
C3b covalently bound to IgG de ...... activation by factors H and I.
@en
prefLabel
C3b covalently bound to IgG de ...... activation by factors H and I.
@ast
C3b covalently bound to IgG de ...... activation by factors H and I.
@en
P2093
P2860
P356
P1476
C3b covalently bound to IgG de ...... activation by factors H and I.
@en
P2093
P2860
P304
P356
10.1084/JEM.160.6.1640
P407
P577
1984-12-01T00:00:00Z